Effects of Recombinant Human Angiotensin-Converting Enzyme 2 on Response to Acute Hypoxia and Exercise: A Randomised, Placebo-Controlled Study.
David A HallKate HanrottPhilipp BadorrekDominik BerlinerDavid C BuddRhena EamesWilliam M PowleyDeborah HewensSarah SiedererAili L LazaarAnthony CahnJens M HohlfeldPublished in: Pulmonary therapy (2021)
A single IV dose of GSK2586881 0.8 mg/kg was well tolerated but did not impact the acute HPV response in healthy volunteers.
Keyphrases
- angiotensin converting enzyme
- liver failure
- recombinant human
- respiratory failure
- angiotensin ii
- double blind
- clinical trial
- drug induced
- aortic dissection
- physical activity
- high intensity
- hepatitis b virus
- endothelial cells
- study protocol
- intensive care unit
- extracorporeal membrane oxygenation
- placebo controlled
- mechanical ventilation
- cell proliferation
- cervical cancer screening